A clinical trial involving angiotensin II was updated on September 25, 2026. The study, titled "Vascular Function in Health and Disease," is registered under identifier NCT02966665. It is listed as a Phase 1 trial. Its current status is recruiting, according to the trial record. The trial record does not include results or outcome data at this time. No efficacy or safety conclusions are stated in the available update. Angiotensin II remains an approved compound, and this listing reflects only the recruitment status of this specific study. Readers interested in the design or purpose of the trial can consult the official registry entry for further details. As with any recruiting trial, status may change as enrollment progresses. This brief reports only the facts contained in the trial update, including its title, phase, and status. No additional claims about the compound's effects are made or implied here. For more background on angiotensin II, including its approved uses and general profile, see the compound overview.
Angiotensin II Trial "Vascular Function in Health and Disease" Recruiting
See the full angiotensin ii overview
Source: https://clinicaltrials.gov/study/NCT02966665